汇宇制药：注射用紫杉醇(白蛋白结合型)获得两份境外上市许可

Core Viewpoint - Seacross (Europe) Pharma Ltd. and Seacross Pharmaceuticals Ltd., subsidiaries of Huayu Pharmaceutical, have received marketing approvals for their injectable paclitaxel (albumin-bound) from regulatory authorities in Portugal and the UK [1] Group 1: Regulatory Approvals - The injectable paclitaxel (albumin-bound) has been successfully developed and has received marketing authorization in multiple countries [1] - The product is now approved for sale in the UK, Portugal, Denmark, Netherlands, Ireland, Finland, and Sweden [1]